CBLL1 and hepatocellular carcinoma: Moreover, the differential expression of other components of the writer complex was also significantly related to RFS in patients with HCC (log-rank test, p < 0.05), except for CBLL1 (Figure 5B), which may be related to the low number of HCC patients with CBLL1 upregulation in the TCGA database whose RFS was longer than 60 months, leading to statistical bias.